Yong Zhu
Professor
CPH | Epidemiology
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Yong Zhu is a molecular epidemiologist whose research focuses on identifying biomarkers associated with cancer risk, progression, and survival, with an emphasis on their translational implications. His laboratory investigates the impact of circadian factors, including night shift work and variations in circadian genes, on tumorigenesis. Additionally, his work involves translational research into small noncoding RNAs, exploring their role in disease processes.
Dr. Zhu's research has been supported by federal grants, including an NIH/National Cancer Institute award of $411,876 to explore piRNAs as potential biomarkers for early ovarian cancer detection. His scholarly contributions are evidenced by a high-impact researcher designation, with an h-index of 41 and over 5,400 citations across 135 publications. He leads a research group and maintains an active laboratory website, fostering collaboration within the University of Arkansas for Medical Sciences with individuals such as Yujuan Guo and Danny Baxter.
Metrics
- h-index: 41
- Publications: 135
- Citations: 5,411
Positions
-
Professor 2024–presentUniversity of Arkansas for Medical Sciences CPH | Epidemiology Institutional directory
Selected Publications
-
hsa_circ_0063865 regulates cytoskeleton rearrangement and endoplasmic reticulum stress to promote esophageal tumorigenesis under co-exposure to N-nitrosamines and microcystin (2026)
-
Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer. (2026)
-
Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer. (2026)
-
Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer (2025)
-
Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening (2025)
-
Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors (2025)
Federal Grants 1 $411,876 total
Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection
Grants & Funding
As listed on this researcher's institutional profile. Federal awards with verified records are shown above.
- ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas Principal Investigator
- Zhu 2025-2027 Rural Research Award Program CI Cancer Institute Principal Investigator
Collaboration Network
Top Collaborators
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- hsa_circ_0063865 regulates cytoskeleton rearrangement and endoplasmic reticulum stress to promote esophageal tumorigenesis under co-exposure to N-nitrosamines and microcystin
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer.
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
- Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer
- Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer.
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors
- Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening
Similar Researchers
Based on overlapping research topics